58303-63-2

Upstream product

• 99-90-1 para-bromoacetophenone 
• 95-92-1 oxalic acid diethyl ester 
• 60395-85-9 methyl 4-(4-bromophenyl)-2,4-dioxobutanoate 

Downstream Products

• 134949-94-3 (E)-5,5'-bis-(4-bromo-phenyl)-[3,3']bifurylidene-2,2'-dione 
• 64393-80-2 2-[2-(4-bromo-phenyl)-2-oxo-ethylidene]-4H-benzo[1,4]thiazin-3-one 
• 81385-14-0 (Z)-4-(4-Bromo-phenyl)-2-(2-mercapto-ethylamino)-4-oxo-but-2-enoic acid 
• 103311-10-0 2-[2-(4-Bromo-phenyl)-2-oxo-ethyl]-4H-benzo[4,5]imidazo[1,2-b][1,2,4]triazin-3-one 
• 55991-70-3 5-(4-bromo-phenyl)-furan-2,3-dione 
• 70372-51-9 (Z)-3-(2-(4-bromophenyl)-2-oxoethylidene)-3,4-dihydro-2H-benzo[b][1,4]oxazin-2-one 
• 66394-51-2 (Z)-3-[2-(4-bromophenyl)-2-oxoethylidene]-3,4-dihydroquinoxalin-2(1H)-one 

Relevant academic research and scientific papers

Non-peptide-based new class of platelet aggregation inhibitors: Design, synthesis, bioevaluation, SAR, and in silico studies

A series of 2-oxo-2-phenylethylidene linked 2-oxo-benzo[1,4]oxazine analogues 17a–x and 18a–o, incorporated with a variety of electron-withdrawing as well as electron-donating groups at ring A and ring C, were synthesized under greener conditions in excel